Tarik Lott

Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic

A. Mangraviti, H. Brem, B. Tyler, 2017, Oncogene.

The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?

H. Brem, B. Tyler, R. Kast, 2019, Molecular Cancer Therapeutics.

Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors

C. Eberhart, T. Zhao, H. Brem, 2018, Oncotarget.

Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma.

H. Brem, B. Tyler, N. Skuli, 2021, Journal of neurosurgery. Pediatrics.